<p>Fulcrum Capital LLC 在第一季度削减了对 Stryker Co.（纽约证券交易所代码：SYK - 免费报告）的持股比例，减少了 69.3%，根据其最近向证券交易委员会（SEC）的披露。这家机构投资者在本季度出售了 1,327 股后，持有该医疗技术公司 588 股股票。根据 Fulcrum Capital LLC 最近向证券交易委员会（SEC）提交的文件，其在 Stryker 的持股价值为 219,000 美元。</p>
<ul>
<li>如果你只能持有 3 项投资一辈子，请考虑这些</li>
</ul>
<p>其他一些对冲基金也对其在 SYK 的持仓进行了调整。Kohmann Bosshard Financial Services LLC 在第四季度购买了价值约 25,000 美元的 Stryker 新头寸。Capital A Wealth Management LLC 在第四季度获得了价值约 26,000 美元的 Stryker 新头寸。Rakuten Securities Inc. 在第四季度将其在 Stryker 的持股增加了 618.2%。Rakuten Securities Inc. 现在拥有 79 股该医疗技术公司的股票，价值 28,000 美元，此前在上个季度又购买了 68 股。Centricity Wealth Management LLC 在第四季度获得了价值约 30,000 美元的 Stryker 新头寸。最后，BankPlus Trust Department 在第四季度获得了价值约 33,000 美元的 Stryker 新头寸。77.09% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>分析师设定新目标价</h2>
<p>几位股票分析师对该公司发表了评论。JMP Securities 在 5 月 5 日的报告中重申了对 Stryker 股票的 “市场表现” 评级。Sanford C. Bernstein 在 5 月 5 日的研究报告中设定了 Stryker 股票的目标价为 450.00 美元。Evercore ISI 在 5 月 2 日的研究报告中将 Stryker 股票的目标价从 400.00 美元下调至 390.00 美元，并对该股票给予 “跑赢大盘” 的评级。Roth Mkm 在 5 月 2 日的研究报告中将 Stryker 股票的目标价从 405.00 美元上调至 456.00 美元，并给予该股票 “买入” 评级。最后，Argus 在 2 月 3 日的研究报告中设定了 Stryker 股票的目标价为 450.00 美元。五位分析师对该股票给予持有评级，十五位分析师给予买入评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 427.30 美元。</p>
<ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
<p><strong>查看我们最新的 Stryker 股票报告</strong></p>
<h2>Stryker 的内部买卖</h2>
<p>在其他 Stryker 新闻中，董事 Ronda E. Stryker 于 5 月 6 日出售了 200,000 股 Stryker 股票。该股票以平均价格 376.96 美元出售，总交易额为 75,392,000.00 美元。交易完成后，该董事现在直接拥有 3,417,326 股公司股票，价值约 1,288,195,208.96 美元。这笔交易代表了他们持有股票的 5.53% 的减少。该出售在向证券交易委员会的法律文件中披露，可以通过此链接访问。公司内部人士持有公司股票的 5.20%。</p>
<h2>Stryker 股票上涨 0.1%</h2>
<ul>
<li>Stryker 的收购狂潮：双位数增长在望</li>
</ul>
<p>SYK 周五开盘价为 382.86 美元。Stryker Co. 的 52 周低点为 314.93 美元，52 周高点为 406.19 美元。该公司的债务与股本比率为 0.59，流动比率为 1.95，速动比率为 1.32。该公司的 50 日移动平均价格为 368.77 美元，200 日移动平均价格为 376.22 美元。该公司的市值为 1461.3 亿美元，市盈率为 49.34，市盈增长比率为 2.93，贝塔值为 0.93。</p>
<p>Stryker（纽约证券交易所代码：SYK - 获取免费报告）最近于 5 月 1 日发布了季度财报。这家医疗技术公司报告的每股收益为 2.84 美元，超出分析师一致预期的 2.73 美元，超出 0.11 美元。该公司本季度的收入为 58.7 亿美元，而一致预期为 56.8 亿美元。Stryker 的净利润率为 13.25%，股本回报率为 23.58%。与去年同期相比，该公司的收入增长了 11.9%。在去年同期，该公司每股收益为 2.50 美元。分析师预计 Stryker Co. 本年度将发布 13.47 美元的每股收益。</p>
<h2>Stryker 宣布分红</h2>
<p>该公司最近还披露了季度分红，将于 7 月 31 日支付。6 月 30 日的股东将获得每股 0.84 美元的分红。该分红的除息日为 6 月 30 日。这代表了每年 3.36 美元的分红和 0.88% 的分红收益率。Stryker 的派息比率目前为 45.41%。</p>
<h2>关于 Stryker</h2>
<p>（免费报告）</p>
<p>Stryker Corporation 作为一家医疗技术公司运营。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 Stryker</li>
<li>什么是道琼斯狗策略？概述和示例</li>
<li>AXON：随着摩托罗拉进行 44 亿美元收购，竞争加剧</li>
<li>什么是上海证券交易所综合指数？</li>
<li>MarketBeat 周评 – 05/26 - 05/30</li>
<li>拥有债券的风险</li>
<li>Nike 在亚马逊的扩张可能预示着 2025 年的转机</li>
</ul>
<p><strong>想看看其他对冲基金持有的 SYK 吗？</strong> 访问 HoldingsChannel.com 获取 Stryker Co.（纽约证券交易所代码：SYK - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
<p>在考虑史赛克之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

<p>Fulcrum Capital LLC 在第一季度减少了对史赛克（Stryker Co.，NYSE:SYK）69.3% 的持股，目前持有 588 股，价值 219,000 美元。其他对冲基金也调整了他们的持仓。分析师设定了不同的价格目标，普遍目标为 427.30 美元。史赛克的股票开盘价为 382.86 美元，市值为 1461.3 亿美元。该公司报告第一季度每股收益为 2.84 美元，超出预期，并宣布将于 7 月 31 日支付每股 0.84 美元的季度股息</p>

<p>Fulcrum Capital LLC trimmed its stake in Stryker Co. (NYSE:SYK - Free Report) by 69.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 588 shares of the medical technology company's stock after selling 1,327 shares during the quarter. Fulcrum Capital LLC's holdings in Stryker were worth $219,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Fulcrum Capital LLC 在第一季度削减了对 Stryker Co.（纽约证券交易所代码：SYK - 免费报告）的持股比例，减少了 69.3%，根据其最近向证券交易委员会（SEC）的披露。这家机构投资者在本季度出售了 1,327 股后，持有该医疗技术公司 588 股股票。根据 Fulcrum Capital LLC 最近向证券交易委员会（SEC）提交的文件，其在 Stryker 的持股价值为 219,000 美元。</p>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 项投资一辈子，请考虑这些</li>
</ul>
</div><p>A number of other hedge funds have also made changes to their positions in SYK. Kohmann Bosshard Financial Services LLC bought a new position in Stryker during the fourth quarter valued at approximately $25,000. Capital A Wealth Management LLC acquired a new position in Stryker during the fourth quarter valued at approximately $26,000. Rakuten Securities Inc. grew its holdings in Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares during the last quarter. Centricity Wealth Management LLC acquired a new position in Stryker during the fourth quarter valued at approximately $30,000. Finally, BankPlus Trust Department acquired a new position in Stryker during the fourth quarter valued at approximately $33,000. 77.09% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金也对其在 SYK 的持仓进行了调整。Kohmann Bosshard Financial Services LLC 在第四季度购买了价值约 25,000 美元的 Stryker 新头寸。Capital A Wealth Management LLC 在第四季度获得了价值约 26,000 美元的 Stryker 新头寸。Rakuten Securities Inc. 在第四季度将其在 Stryker 的持股增加了 618.2%。Rakuten Securities Inc. 现在拥有 79 股该医疗技术公司的股票，价值 28,000 美元，此前在上个季度又购买了 68 股。Centricity Wealth Management LLC 在第四季度获得了价值约 30,000 美元的 Stryker 新头寸。最后，BankPlus Trust Department 在第四季度获得了价值约 33,000 美元的 Stryker 新头寸。77.09% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several equities analysts have commented on the company. JMP Securities reiterated a &#34;market perform&#34; rating on shares of Stryker in a report on Monday, May 5th. Sanford C. Bernstein set a $450.00 price objective on shares of Stryker in a research note on Monday, May 5th. Evercore ISI lowered their price objective on shares of Stryker from $400.00 to $390.00 and set an &#34;outperform&#34; rating on the stock in a research note on Friday, May 2nd. Roth Mkm raised their price objective on shares of Stryker from $405.00 to $456.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, May 2nd. Finally, Argus set a $450.00 price objective on shares of Stryker in a research note on Monday, February 3rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $427.30.</p>
<div class="lb-trans"><p>几位股票分析师对该公司发表了评论。JMP Securities 在 5 月 5 日的报告中重申了对 Stryker 股票的 “市场表现” 评级。Sanford C. Bernstein 在 5 月 5 日的研究报告中设定了 Stryker 股票的目标价为 450.00 美元。Evercore ISI 在 5 月 2 日的研究报告中将 Stryker 股票的目标价从 400.00 美元下调至 390.00 美元，并对该股票给予 “跑赢大盘” 的评级。Roth Mkm 在 5 月 2 日的研究报告中将 Stryker 股票的目标价从 405.00 美元上调至 456.00 美元，并给予该股票 “买入” 评级。最后，Argus 在 2 月 3 日的研究报告中设定了 Stryker 股票的目标价为 450.00 美元。五位分析师对该股票给予持有评级，十五位分析师给予买入评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 427.30 美元。</p>
</div><ul>
<li>3 Stocks Helping to Bring AI to Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
</div><p><strong>View Our Latest Stock Report on Stryker</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Stryker 股票报告</strong></p>
</div><h2>Insider Buying and Selling at Stryker</h2>
<div class="lb-trans"><h2>Stryker 的内部买卖</h2>
</div><p>In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the transaction, the director now directly owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this link. Company insiders own 5.20% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Stryker 新闻中，董事 Ronda E. Stryker 于 5 月 6 日出售了 200,000 股 Stryker 股票。该股票以平均价格 376.96 美元出售，总交易额为 75,392,000.00 美元。交易完成后，该董事现在直接拥有 3,417,326 股公司股票，价值约 1,288,195,208.96 美元。这笔交易代表了他们持有股票的 5.53% 的减少。该出售在向证券交易委员会的法律文件中披露，可以通过此链接访问。公司内部人士持有公司股票的 5.20%。</p>
</div><h2>Stryker Stock Up 0.1%</h2>
<div class="lb-trans"><h2>Stryker 股票上涨 0.1%</h2>
</div><ul>
<li>Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon</li>
</ul>
<div class="lb-trans"><ul>
<li>Stryker 的收购狂潮：双位数增长在望</li>
</ul>
</div><p>SYK opened at $382.86 on Friday. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm's fifty day moving average price is $368.77 and its two-hundred day moving average price is $376.22. The company has a market capitalization of $146.13 billion, a P/E ratio of 49.34, a P/E/G ratio of 2.93 and a beta of 0.93.</p>
<div class="lb-trans"><p>SYK 周五开盘价为 382.86 美元。Stryker Co. 的 52 周低点为 314.93 美元，52 周高点为 406.19 美元。该公司的债务与股本比率为 0.59，流动比率为 1.95，速动比率为 1.32。该公司的 50 日移动平均价格为 368.77 美元，200 日移动平均价格为 376.22 美元。该公司的市值为 1461.3 亿美元，市盈率为 49.34，市盈增长比率为 2.93，贝塔值为 0.93。</p>
</div><p>Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The firm had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The business's revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.50 earnings per share. On average, analysts anticipate that Stryker Co. will post 13.47 EPS for the current year.</p>
<div class="lb-trans"><p>Stryker（纽约证券交易所代码：SYK - 获取免费报告）最近于 5 月 1 日发布了季度财报。这家医疗技术公司报告的每股收益为 2.84 美元，超出分析师一致预期的 2.73 美元，超出 0.11 美元。该公司本季度的收入为 58.7 亿美元，而一致预期为 56.8 亿美元。Stryker 的净利润率为 13.25%，股本回报率为 23.58%。与去年同期相比，该公司的收入增长了 11.9%。在去年同期，该公司每股收益为 2.50 美元。分析师预计 Stryker Co. 本年度将发布 13.47 美元的每股收益。</p>
</div><h2>Stryker Announces Dividend</h2>
<div class="lb-trans"><h2>Stryker 宣布分红</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's payout ratio is presently 45.41%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，将于 7 月 31 日支付。6 月 30 日的股东将获得每股 0.84 美元的分红。该分红的除息日为 6 月 30 日。这代表了每年 3.36 美元的分红和 0.88% 的分红收益率。Stryker 的派息比率目前为 45.41%。</p>
</div><h2>About Stryker</h2>
<div class="lb-trans"><h2>关于 Stryker</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>Stryker Corporation 作为一家医疗技术公司运营。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>What is the Dogs of the Dow Strategy? Overview and Examples</li>
<li>AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>MarketBeat Week in Review – 05/26 - 05/30</li>
<li>The Risks of Owning Bonds</li>
<li>Nike’s Amazon Expansion Could Signal a Turnaround in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Stryker</li>
<li>什么是道琼斯狗策略？概述和示例</li>
<li>AXON：随着摩托罗拉进行 44 亿美元收购，竞争加剧</li>
<li>什么是上海证券交易所综合指数？</li>
<li>MarketBeat 周评 – 05/26 - 05/30</li>
<li>拥有债券的风险</li>
<li>Nike 在亚马逊的扩张可能预示着 2025 年的转机</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding SYK?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 SYK 吗？</strong> 访问 HoldingsChannel.com 获取 Stryker Co.（纽约证券交易所代码：SYK - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑史赛克之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Fulcrum Capital LLC 减少了其持有的史赛克公司（NYSE:SYK）股票头寸